![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 41, 28861-28864, October 8, 1999
, andFrom the Departments of Medicine and of Microbiology and Immunology, Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, California 94143
| |
ABSTRACT |
|---|
|
|
|---|
LAT, a transmembrane adapter protein found in
glycolipid-enriched microdomains (GEMs), is essential for T cell
activation. In this study, we have utilized a LAT-deficient mutant of
the Jurkat T cell line, J.CaM2, to explore various requirements for LAT
function. First, we demonstrate that LAT must be present in GEMs for
coupling T cell receptor (TCR) engagement to activation of the Ras
signaling pathway, increases in intracellular Ca2+,
and induction of the transcription factor nuclear factor of activated T
cells (NF-AT). Second, we show that the extracellular and transmembrane
domains of LAT are dispensable for these TCR-mediated events once LAT
has localized to GEMs. These results provide important insights into
both the structural domains of LAT and its subcellular localization
that are required for effective TCR signaling.
Engagement of the T cell receptor
(TCR)1 with either antigen or
antibodies that bind TCR subunits results in the initiation of an
intracellular signaling cascade, a complex series of biochemical events
that culminate in T cell proliferation, differentiation, and gain of
effector functions (1, 2). The earliest of the signal transduction
processes that occur following TCR stimulation include the activation
of Src (Lck, Fyn) and Syk (ZAP-70, Syk) families of tyrosine kinases.
These kinases subsequently phosphorylate downstream substrates allowing
for a continuation of the signaling cascade. Phosphorylation of
substrates by Src and Syk kinases can mediate the induction of
enzymatic activity, for example with Vav and phospholipase C One molecule that becomes heavily tyrosine phosphorylated in response
to TCR engagement is LAT (Linker for Activation
of T Cells), a transmembrane protein whose expression is
limited to T, NK, and mast cells. Although LAT lacks intrinsic
enzymatic activity, tyrosine phosphorylation at multiple tyrosine
residues within LAT facilitates its association with a number of
signaling molecules that may contribute to T cell activation, including Grb2, GADs, the p85 subunit of phosphatidylinositol 3-kinase, PLC LAT contains a very short extracellular region, a transmembrane domain,
and a tyrosine-rich cytoplasmic tail. Consistent with these structural
features, LAT is found predominantly in the plasma membrane of T cells
(14, 15, 17). Furthermore, LAT is palmitoylated on two conserved
cysteines (amino acids 26 and 29), and this modification localizes LAT
to glycolipid-enriched microdomains (GEMs) within the plasma membrane
(21). GEMs, sometimes referred to as detergent-insoluble lipid rafts,
have been proposed to function as platforms for the formation of
multi-component signaling complexes (22). Interestingly, other
molecules in addition to LAT, including Lck, Vav, Grb2, PLC In this report, we demonstrate that LAT must be present in GEMs for the
activation of the Ras pathway, an increase in intracellular Ca+2, and the stimulation of NF-AT-dependent
transcriptional activity in response to TCR engagement. Also, we show
that the extracellular and transmembrane domains of LAT are not
required for these processes once LAT has localized to GEMs.
Cell Lines and Reagents--
The LAT-deficient Jurkat T cell
derivative J.CaM2 (26) was maintained in RPMI 1640 supplemented with
10% fetal bovine serum, 2 mM glutamine, penicillin, and
streptomycin. Cells were stimulated with C305, an anti-Jurkat Ti Purification of GEM Fractions--
2 × 107
J.CaM2 cells were transfected and 20 h later were lysed on ice in
1 ml of 0.5% Triton X-100 in TNE buffer (25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 5 mM EDTA) with a
combination of protease and phosphatase inhibitors. All subsequent
steps were performed at 4 °C. Lysates were mixed with 80% sucrose
in TNE, transferred to centrifuge tubes, and overlaid with 2 ml of 30%
sucrose in TNE and then 1 ml of 5% sucrose in TNE. Samples were
centrifuged for 20-22 h at 45,000 rpm in a Beckman SW55Ti at 4 °C,
and twelve 400-µl fractions were collected from the top of each gradient.
Transfection, Stimulation, and Luciferase Assay--
For
transient transfections, 2 × 107 J.CaM2 cells in 400 µl of RPMI 1640 were electroporated at 250 V, 960 microfarads with 30-50 µg of DNA total. Unless otherwise noted, 2.5-10 µg of the various LAT vectors were used to obtain equal protein expression. TCR
stimulation for analysis of LAT and ERK2 phosphorylation involved incubating PBS-washed cells (8 × 107cells/ml) at
37 °C for 15 min followed by addition of anti-TCR mAb (1:500) or PBS
as a control for 2 min. Cells were immediately pelleted and lysed. For
TCR stimulation in luciferase assays, cells were either left untreated
or were incubated with immobilized anti-TCR mAb or PMA (25 ng/ml) and
ionomycin (1 µM) for 6 h. Cells were then harvested,
lysed, and assayed for luciferase activity (29).
Preparation of Lysates, Immunoprecipitation, and Western
Blotting--
Cells were lysed at 107 cells/150 µl in
lysis buffer (1% Nonidet P-40, 150 mM NaCl, 10 mM Tris-HCl, pH 7.6, 2 mM EDTA, and protease
and phosphatase inhibitors). After a 10-min incubation on ice, samples
were clarified by centrifugation at 14,000 rpm for 10 min. For
immunoprecipitations, lysates were incubated with primary antibody for
at least 1 h and then protein G-Sepharose beads for 1 h.
Beads were then washed three times in 500 µl of lysis buffer. Samples
were resuspended in reducing SDS sample buffer, heated at 95 °C for
5 min, and separated by SDS-PAGE, and proteins were transferred to
Immobilon-P (Millipore) for analysis by Western blotting. Membranes
were blocked with 3% bovine serum albumin, incubated with the
indicated primary antibodies followed by the appropriate secondary
antibody conjugated to horseradish peroxidase. Reactive proteins were
subsequently visualized by enhanced chemiluminescence (Amersham
Pharmacia Biotech).
Measurement of Intracellular Ca2+ Levels--
J.CaM2
cells were transfected with the various LAT constructs and 20 µg of
vector encoding CD8. 20 h after transfection, cells were incubated
with anti-CD8 mAb conjugated to phycoerythrin (Becton Dickinson), then
washed and incubated with the Ca2+ indicator Fluo-3-AM
(Molecular Probes) at a final concentration of 2.5 µM.
After a 30-min incubation, samples were again washed, resuspended in 1 ml, and subsequently warmed to 37 °C for 5 min prior to analysis by
FACScan (Becton Dickinson).
LAT Localization to GEMs Is Required for Function--
Although
palmitoylation of LAT on cysteines 26 and 29 is not necessary for LAT
localization to the plasma membrane, it is essential for its
distribution into GEMs (21). To determine whether the presence of LAT
within GEMs is required for coupling TCR engagement to downstream
signaling events, an expression vector was created encoding a form of
LAT containing serines instead of cysteines at these palmitoylation
sites (C26/29S-LAT). Although C26/29S-LAT was expressed at levels
similar to wild-type LAT (WT-LAT) following transfection of vectors
encoding either protein into LAT-deficient J.CaM2 T cells (Fig.
1A), C26/29S-LAT was
completely absent in GEM fractions and, instead, was found exclusively
in the Triton-soluble fraction (Fig. 1B). Conversely, a
majority of transfected WT-LAT was found in GEMs with little detected
in the Triton-soluble fraction (Fig. 1B). To ensure that our
method of GEM isolation yielded fractions devoid of
cross-contamination, we also assayed for the presence of markers that
specifically localize to GEM and Triton-soluble fractions, namely the
ganglioside GM1 (using cholera toxin) and ZAP-70, respectively.
Consistent with other studies (21, 25), we detected the ganglioside GM1 only in the GEM fraction and ZAP-70 only in the Triton-soluble fraction
of unstimulated cells (data not shown).
Following TCR engagement, LAT becomes heavily tyrosine phosphorylated.
To determine whether LAT localization to GEMs is required for its
inducible tyrosine phosphorylation, J.CaM2 cells were transfected with
vectors encoding either WT-LAT or C26/29S-LAT and subsequently
stimulated through the TCR followed by the analysis of LAT
phosphorylation. Surprisingly, C26/29S-LAT was constitutively phosphorylated on tyrosine residues in the basal state (Fig.
2). However, consistent with previous
results (21), the inability of LAT to localize to GEMs correlated in
its lack of inducible tyrosine phosphorylation following TCR
stimulation (Fig. 2). As expected, tyrosine phosphorylation of
transfected WT-LAT was not appreciable in the basal state but increased
dramatically following TCR engagement (Fig. 2). Thus, mutation of
cysteines 26 and 29 to serines in LAT abrogated its localization to
GEMs and resulted in its constitutive tyrosine phosphorylation. In
addition, C26/29S-LAT also failed to display enhanced tyrosine
phosphorylation following TCR engagement.
In contrast to the response seen in wild-type Jurkat T cells following
TCR engagement, LAT-deficient J.CaM2 cells fail to display an
activation of the Ras signaling pathway, an increase in intracellular
Ca2+, or an induction of the transcription factor NF-AT.
Importantly, re-expression of wild type LAT in J.CaM2 restores all of
these processes (19). Because C26/29S-LAT exhibited a significant constitutive level of tyrosine phosphorylation in J.CaM2, it was conceivable that it may be able to function in TCR-mediated signaling despite its inability to associate with GEMs or display inducible tyrosine phosphorylation. To examine this possibility, C26/29S-LAT was
transfected into J.CaM2 and cells were subsequently stimulated through
the TCR receptor followed by analysis for Ras activation, intracellular
Ca2+ increases, and NF-AT induction. Control experiments
were performed in tandem by transfecting J.CaM2 with either empty
vector or a vector encoding WT-LAT.
To examine the Ras signaling pathway, we focused on the phosphorylation
of Erk2, which occurs as a consequence of Ras activation in T cells
following TCR engagement (30). Consistent with previous results (19),
J.CaM2 cells receiving WT-LAT, but not empty vector, demonstrated Erk2
phosphorylation following TCR engagement (Fig. 3A). Interestingly, cells
expressing C26/29S-LAT failed to exhibit Erk2 phosphorylation in
response to TCR stimulation (Fig. 3B). A similar pattern of
results was seen when the levels of intracellular Ca2+ and
induction of NF-AT were analyzed; cells receiving WT-LAT but not
C26/29S-LAT restored intracellular Ca2+ mobilization (Fig.
3B) and activation of NF-AT (Fig.
4) in response to TCR engagement.
Together these results indicate that LAT localization to GEMs is
required for coupling TCR stimulation with downstream signaling
events.
The Extracellular and Transmembrane Domains of LAT Are Dispensable
for Function--
As an initial step toward identifying regions of LAT
required for function, we focused on its extracellular and
transmembrane domains. Because our results suggested that LAT must
localize to GEMs to facilitate activation of downstream signaling
pathways, we studied the role of these domains in the context of GEMs.
A vector was created that encoded a form of LAT where the extracellular and transmembrane domains were replaced with the first 10 amino acids
from the N terminus of Lck (Lck-LAT). This Lck motif provides the
necessary signals for myristoylation and palmitoylation and when
attached to a heterologous protein can target it to GEMs (31). Thus,
Lck-LAT should localize to GEMs but will lack both the extracellular
and transmembrane domains of LAT. As shown in Fig. 1, A and
B, respectively, Lck-LAT was expressed at levels comparable
with WT-LAT and localized primarily to the GEM fraction of cell lysates.
We next analyzed Lck-LAT phosphorylation, and in a manner similar to
WT-LAT, Lck-LAT became heavily tyrosine phosphorylated after engagement
of the TCR (Fig. 2). Furthermore, cells expressing Lck-LAT demonstrated
TCR-mediated activation of the Ras signaling pathway (Fig.
3A), mobilization of intracellular Ca2+ (Fig.
3B), and induction of NF-AT (Fig. 4). Taken together, the results obtained with Lck-LAT demonstrated that once LAT localizes to
GEMs, both its extracellular and transmembrane domains were dispensable
for coupling TCR engagement to the activation of downstream signaling pathways.
Glycolipid-enriched microdomains (GEMs) have increasingly been
implicated as critical components of intracellular signaling cascades.
In T cells for instance, a number of important signaling molecules have
been shown to localize to GEMs, either constitutively or following TCR
stimulation. In addition, treatment of T cells with various agents that
disrupt GEM structure can inhibit effective TCR signaling (25). Thus,
the formation of GEM-dependent, higher order signaling
complexes may play a central role in T cell activation.
The contribution of LAT to T cell activation likely derives from its
TCR-mediated tyrosine phosphorylation, a process which facilitates LAT
association with multiple signaling proteins, including Grb2, GADs,
SLP-76, Vav, PLC In this study we also addressed which domains of LAT are critical for
function once the protein has localized to GEMs. In particular, we
focused on the potential role of the extracellular and transmembrane
domains. A comparison of LAT protein sequences from mouse, human, and
rat revealed the presence of a conserved,
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1
(PLC
-1) (3-6), and may also facilitate protein-protein
interactions, such as with SLP-76 and Cbl (7-12). Both of these
outcomes of tyrosine phosphorylation are critical for effective T cell activation.
-1,
Vav, SLP-76, and Cbl (13-18). An essential role for LAT in T cell
activation has been revealed through the characterization of J.CaM2, a
LAT-deficient derivative of the Jurkat T cell line (19). J.CaM2 cells
fail to produce many of the TCR-derived signaling events required for T
cell activation, including activation of the Ras pathway, elevation in
intracellular Ca2+, and induction of the transcription
factor NF-AT. Importantly, re-expression of wild-type LAT in J.CaM2
restores all of these processes (19). More recently, the analysis of
mice that lack LAT expression has also revealed a necessary role for
this molecule in T cell development (20).
-1, and
Ras, are also either constitutively associated with GEMs or
redistribute into GEMs following TCR engagement (21, 23-25). However,
it remains unclear whether the localization of specific molecules to
GEMs is actually necessary for their function in T cell signaling.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
chain mAb (27). The anti-phosphotyrosine mAb, 4G10, and the
anti-phospho-ERK2 antibody were obtained from Upstate Biotechnology,
Inc. and New England Biolabs, respectively. Anti-Myc mAb was derived
from the 9E10 hybridoma. Antibodies for LAT (17), Lck (28), and ZAP-70
(19) have been previously described. For use in transfections, a
myc-tagged form of LAT was excised from pBluescript with
EcoRI and XbaI and inserted into the expression
vector, pcdef3. C26/29S-LAT, also in pcdef3, was created with the
QuickChange site-directed mutagenesis kit (Stratagene). The Lck-LAT
chimera was made by digesting pcdef3-LAT with EcoRI and
ApaLI to remove the extracellular and transmembrane domains
of LAT and replacing this region, in frame, with an oligo encoding the
N terminus 10 amino acids of Lck. Erk2 and CD8 were expressed from
pEF-BOS. The NF-AT-luciferase reporter plasmid has been previously
described (29).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (28K):
[in a new window]
Fig. 1.
Localization of LAT variants to
glycolipid-enriched microdomains (GEMs). J.CaM2
cells were transfected with the various myc-tagged LAT constructs, and
20 h later cells were lysed. A, half of the cells were
lysed in 1% Nonidet P-40, separated by SDS-PAGE, and analyzed by
Western blot with an anti-Myc mAb to detect LAT. B, the
remaining cells were lysed in 0.5% Triton and subjected to
ultracentrifugation in a sucrose gradient to purify GEMs. The GEM
fraction (fraction 3) and a Triton-soluble fraction (fraction 11) were
separated by SDS-PAGE and analyzed by Western blot with an anti-Myc mAb
to detect LAT (the slightly faster mobility band detected in
empty-vector-transfected cells is because of nonspecific
cross-reactivity). Blots of fraction 3 and 11 were also probed with
anti-Lck and anti-ZAP-70 antibodies respectively to verify equal
loading of samples. wt LAT, wild-type LAT.

View larger version (45K):
[in a new window]
Fig. 2.
Tyrosine phosphorylation of LAT variants in
response to TCR stimulation. J.CaM2 cells were transfected with
the myc-tagged LAT constructs and 20 h later were stimulated for 2 min with C305 or a PBS control. Cells were subsequently lysed and
LAT-immunoprecipitated with an anti-LAT antibody, and
immunoprecipitated proteins were separated by SDS-PAGE. Proteins were
transferred to membrane and analyzed by Western blotting with an
anti-Myc mAb to detect LAT. Blots were subsequently stripped and
re-probed with an anti-phosphotyrosine antibody. wt LAT,
wild-type LAT; IP, immunoprecipitate.

View larger version (42K):
[in a new window]
Fig. 3.
TCR-mediated Erk2 phosphorylation and
intracellular Ca2+ levels in the presence of LAT
variants. A, J.CaM2 cells were transfected with 2.5-10
µg of the Myc-tagged LAT constructs (to yield equal protein
expression) and 7.5 µg of Myc-tagged Erk2. 20 h after
transfection, cells were either stimulated with C305 or a PBS control
for 2 min and then lysed, and anti-myc immunoprecipitations were
performed. Immunoprecipitated proteins were separated by SDS-PAGE,
transferred to membrane, and blotted with anti-Myc mAb. Blots were then
stripped and then reprobed with an anti-phospho-ERK2 Ab. B,
cells were transfected with 1-4 µg of the indicated LAT constructs
20 h prior to staining with anti-CD8 mAb conjugated to
phosphatidylethanolamine and loading of the calcium indicator
Fluo-3-AM. Cells were subsequently analyzed by FACScan to determine
intracellular Ca2+ levels. Addition of C305 (1:500) or
ionomycin (final concentration = 1 µM) is
indicated. Intracellular Ca+2 levels shown are for cells
staining positive for transfected CD8. wt LAT,
wild-type LAT; IP, immunoprecipitate.

View larger version (16K):
[in a new window]
Fig. 4.
TCR-mediated NF-AT activity in the presence
of various LAT variants. J.CaM2 cells were transfected with 10-40
ng of the various Myc-tagged LAT vectors (to obtain equal protein
expression) and 15 µg of the NF-AT-luciferase reporter construct.
19 h later, equal numbers of cells were either left untreated or
stimulated with immobilized anti-TCR mAb for 6 h and then lysed,
and the level of luciferase activity was measured. Shown is the average
and standard error in relative light units of three independent
experiments. wt LAT, wild-type LAT.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1, Cbl, and the p85 subunit of phosphatidylinositol
3-kinase. The interaction of these molecules with LAT may result in
their activation and/or may promote protein-protein interactions that
are crucial for downstream signaling events. Here we demonstrate that a
form of the adaptor molecule LAT (C26/29S-LAT) that fails to localize
to GEMs cannot support TCR-mediated signal transduction. These results
are consistent with other studies that have suggested that GEMs play an
important role in T cell activation. More importantly however, our
results strongly suggest that LAT function may depend on its ability to
recruit multiple signaling proteins to GEMs, where proper protein
interactions can form and/or where essential substrates may be located.
Relevant to this idea is the observation that C26/29S-LAT displayed a
high level of basal tyrosine phosphorylation yet could not support productive TCR signaling. One conceivable explanation for this result
is that, although C26/29S-LAT binds critical signaling molecules, it is
unable to couple TCR engagement to downstream signaling processes
because of its failure to localize into GEMs. Alternatively, because
LAT contains nine sites of potential tyrosine phosphorylation, it is
possible that the constitutive sites of tyrosine phosphorylation in
C26/29S-LAT are not those that mediate the recruitment of appropriate
signaling molecules. Of note, previous analysis of a GEM-excluded LAT
variant containing alanines in place of cysteines at residues 26 and 29 did not reveal a high constitutive level of LAT tyrosine
phosphorylation (21). Although an explanation for this discrepancy is
presently lacking, variations in results may reflect the different cell
types utilized (Jurkat versus J.CaM2) or experimental
approaches employed (transient versus stable transfection of
LAT variants).
-helix disrupting proline
within the transmembrane domain, which could potentially destabilize
LAT insertion into lipid bilayers (17, 18). Often, proteins which
contain such atypical amino acids within the transmembrane region are
stabilized through the interaction of this domain with other molecules.
It was therefore possible that LAT interacted with another protein via
its transmembrane domain and that this interaction may be critical for
LAT function. It was also possible that the extracellular and
transmembrane domains were required for LAT function by some other
mechanism. However, our results clearly show that both the
extracellular and transmembrane domains are dispensable in coupling TCR
engagement to the activation of the Ras signaling pathway,
intracellular Ca2+ mobilization, and NF-AT activation. It
is possible that these domains are required for other functions of LAT.
For example, the transmembrane region may initially localize LAT to the
plasma membrane, permitting palmitoylation of LAT on cysteine residues 26 and 29 and thereby resulting in subsequent LAT insertion into GEMs.
Alternatively, the extracellular and transmembrane domains may be
required for coupling TCR engagement to downstream pathways that were
not examined in the present study or that are required for functions
independent of signaling. Future studies will hopefully address these
alternative possibilities.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 415-476-1291;
Fax: 415-502-5081; E-mail: aweiss@itsa.ucsf.edu.
§ Present address: Dept. of Biology, Agnes Scott College, 141 E. College Ave., Decatur, GA 30030.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
TCR, T cell
receptor;
GEM, glycolipid-enriched microdomain;
LAT, linker for
activation of T cells;
NF-AT, nuclear factor of activated T cells;
mAb, monoclonal antibody;
PLC
-1, phospholipase C
-1;
PBS, phosphate-buffered saline;
PAGE, polyacrylamide gel electrophoresis;
WT-LAT, wild-type LAT.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Weiss, A., and Littman, D. R. (1994) Cell 76, 263-274[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Wange, R. L., and Samelson, L. E. (1996) Immunity 5, 197-205[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Secrist, J. P.,
Karnitz, L.,
and Abraham, R. T.
(1991)
J. Biol. Chem.
266,
12135-12139 |
| 4. |
Weiss, A.,
Koretzky, G.,
Schatzman, R. C.,
and Kadlecek, T.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
5484-5488 |
| 5. | Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S., and Bustelo, X. R. (1997) Nature 385, 169-172[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Han, J., Das, B., Wei, W., Van Aelst, L., Mosteller, R. D., Khosravi-Far, R., Westwick, J. K., Der, C. J., and Broek, D. (1997) Mol. Cell. Biol. 17, 1346-1353[Abstract] |
| 7. |
Fournel, M.,
Davidson, D.,
Weil, R.,
and Veillette, A.
(1996)
J. Exp. Med.
183,
301-306 |
| 8. |
Fukazawa, T.,
Reedquist, K. A.,
Trub, T.,
Soltoff, S.,
Panchamoorthy, G.,
Druker, B.,
Cantley, L.,
Shoelson, S. E.,
and Band, H.
(1995)
J. Biol. Chem.
270,
19141-19150 |
| 9. |
Buday, L.,
Khwaja, A.,
Sipeki, S.,
Farago, A.,
and Downward, J.
(1996)
J. Biol. Chem.
271,
6159-6163 |
| 10. |
Reedquist, K. A.,
Fukazawa, T.,
Panchamoorthy, G.,
Langdon, W. Y.,
Shoelson, S.,
Druker, B.,
and Band, H.
(1996)
J. Biol. Chem.
271,
8435-8442 |
| 11. |
Tuosto, L.,
Michel, F.,
and Acuto, O.
(1996)
J. Exp. Med.
184,
1161-1166 |
| 12. | Wu, J., Motto, D. G., Koretzky, G. A., and Weiss, A. (1996) Immunity 4, 593-602[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Gilliland, L. K.,
Schieven, G. L.,
Norris, N. A.,
Kanner, S. B.,
Aruffo, A.,
and Ledbetter, J. A.
(1992)
J. Biol. Chem.
267,
13610-13616 |
| 14. |
Buday, L.,
Egan, S. E.,
Rodriguez-Viciana, P.,
Cantrell, D. A.,
and Downward, J.
(1994)
J. Biol. Chem.
269,
9019-9023 |
| 15. |
Sieh, M.,
Batzer, A.,
Schlessinger, J.,
and Weiss, A.
(1994)
Mol. Cell. Biol.
14,
4435-4442 |
| 16. |
Trubb, T.,
Frantz, J. D.,
Miyazaki, M.,
Band, H.,
and Shoelson, S. E.
(1997)
J. Biol. Chem.
272,
894-902 |
| 17. | Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. P., and Samelson, L. E. (1998) Cell 92, 83-92[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Weber, J. R.,
Orstavik, S.,
Torgersen, K. M.,
Danbolt, N. C.,
Berg, S. F.,
Ryan, J. C.,
Tasken, K.,
Imboden, J. B.,
and Vaage, J. T.
(1998)
J. Exp. Med.
187,
1157-1161 |
| 19. | Finco, T. S., Kadlecek, T., Zhang, W., Samelson, L., and Weiss, A. (1998) Immunity 9, 617-626[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Zhang, W., Sommers, C. L., Burshtyn, D. N., Stebbins, C. C., DeJarnette, J. B., Trible, R. P., Grinberg, A., Tsay, H. C., Jacobs, H. M., Kessler, C. M., Long, E. O., Love, P. E., and Samelson, L. E. (1999) Immunity 10, 323-332[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Zhang, W., Trible, R. P., and Samelson, L. E. (1998) Immunity 9, 239-246[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Simons, K., and Ikonen, E. (1997) Nature 387, 569-572[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Brdiacka, T., Cernay, J., and Hoarejasai, V. (1998) Biochem. Biophys. Res. Commun. 248, 356-360[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Montixi, C., Langlet, C., Bernard, A.-M., Thimonier, J., Dubois, C., Wurbel, M.-A., Chauvin, J.-P., Pierres, M., and He, H.-T. (1998) EMBO J. 17, 5334-5348[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Xavier, R., Brennan, T., Li, Q., McCormack, C., and Seed, B. (1998) Immunity 8, 723-732[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Goldsmith, M. A.,
Dazin, P. F.,
and Weiss, A.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
8613-8617 |
| 27. |
Weiss, A.,
and Stobo, J. D.
(1984)
J. Exp. Med.
160,
1284-1299 |
| 28. |
Burkhardt, A. L.,
Stealey, B.,
Rowley, R. B.,
Mahajan, S.,
Prendergast, M.,
Fargnoli, J.,
and Bolen, J. B.
(1994)
J. Biol. Chem.
269,
23642-23647 |
| 29. |
Shapiro, V. S.,
Mollenauer, M. N.,
Greene, W. C.,
and Weiss, A.
(1996)
J. Exp. Med.
184,
1663-1669 |
| 30. |
Izquierdo, M.,
Leevers, S. J.,
Marshall, C. J.,
and Cantrell, D.
(1993)
J. Exp. Med.
178,
1199-1208 |
| 31. | Zlatkine, P., Mehul, B., and Magee, A. I. (1997) J. Cell Sci. 110, 673-679[Abstract] |
This article has been cited by other articles:
![]() |
D. Beach, R. Gonen, Y. Bogin, I. G. Reischl, and D. Yablonski Dual Role of SLP-76 in Mediating T Cell Receptor-induced Activation of Phospholipase C-{gamma}1 J. Biol. Chem., February 2, 2007; 282(5): 2937 - 2946. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Brown Lipid Rafts, Detergent-Resistant Membranes, and Raft Targeting Signals. Physiology, December 1, 2006; 21(6): 430 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Resh Palmitoylation of Ligands, Receptors, and Intracellular Signaling Molecules Sci. Signal., October 31, 2006; 2006(359): re14 - re14. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kliche, D. Breitling, M. Togni, R. Pusch, K. Heuer, X. Wang, C. Freund, A. Kasirer-Friede, G. Menasche, G. A. Koretzky, et al. The ADAP/SKAP55 Signaling Module Regulates T-Cell Receptor-Mediated Integrin Activation through Plasma Membrane Targeting of Rap1. Mol. Cell. Biol., October 1, 2006; 26(19): 7130 - 7144. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Grossmann, M. Opekarova, L. Novakova, J. Stolz, and W. Tanner Lipid Raft-Based Membrane Compartmentation of a Plant Transport Protein Expressed in Saccharomyces cerevisiae Eukaryot. Cell, June 1, 2006; 5(6): 945 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhang, R. Smith, R. S. Chapkin, and D. N. McMurray Dietary (n-3) Polyunsaturated Fatty Acids Modulate Murine Th1/Th2 Balance toward the Th2 Pole by Suppression of Th1 Development J. Nutr., July 1, 2005; 135(7): 1745 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Roose, M. Mollenauer, V. A. Gupta, J. Stone, and A. Weiss A Diacylglycerol-Protein Kinase C-RasGRP1 Pathway Directs Ras Activation upon Antigen Receptor Stimulation of T Cells Mol. Cell. Biol., June 1, 2005; 25(11): 4426 - 4441. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shogomori, A. T. Hammond, A. G. Ostermeyer-Fay, D. J. Barr, G. W. Feigenson, E. London, and D. A. Brown Palmitoylation and Intracellular Domain Interactions Both Contribute to Raft Targeting of Linker for Activation of T Cells J. Biol. Chem., May 13, 2005; 280(19): 18931 - 18942. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gonen, D. Beach, C. Ainey, and D. Yablonski T Cell Receptor-induced Activation of Phospholipase C-{gamma}1 Depends on a Sequence-independent Function of the P-I Region of SLP-76 J. Biol. Chem., March 4, 2005; 280(9): 8364 - 8370. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. J. Fawcett and U. Lorenz Localization of Src Homology 2 Domain-Containing Phosphatase 1 (SHP-1) to Lipid Rafts in T Lymphocytes: Functional Implications and a Role for the SHP-1 Carboxyl Terminus J. Immunol., March 1, 2005; 174(5): 2849 - 2859. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. O. Meyer zum Bueschenfelde, J. Unternaehrer, I. Mellman, and K. Bottomly Regulated Recruitment of MHC Class II and Costimulatory Molecules to Lipid Rafts in Dendritic Cells J. Immunol., November 15, 2004; 173(10): 6119 - 6124. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Na, A. Patra, Y. Scheuring, A. Marx, M. Tolaini, D. Kioussis, B. Hemmings, T. Hunig, and U. Bommhardt Constitutively Active Protein Kinase B Enhances Lck and Erk Activities and Influences Thymocyte Selection and Activation J. Immunol., August 1, 2003; 171(3): 1285 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Doucey, D. F. Legler, M. Faroudi, N. Boucheron, P. Baumgaertner, D. Naeher, M. Cebecauer, D. Hudrisier, C. Ruegg, E. Palmer, et al. The {beta}1 and {beta}3 Integrins Promote T Cell Receptor-mediated Cytotoxic T Lymphocyte Activation J. Biol. Chem., July 11, 2003; 278(29): 26983 - 26991. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. V. Laethem, X. Liang, F. Andris, J. Urbain, M. Vandenbranden, J.-M. Ruysschaert, M. D. Resh, T. M. Stulnig, and O. Leo Glucocorticoids Alter the Lipid and Protein Composition of Membrane Rafts of a Murine T Cell Hybridoma J. Immunol., March 15, 2003; 170(6): 2932 - 2939. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Wange The Missing Link(er): A Return to Symmetry in Antigen Receptor Signaling? Mol. Interv., March 1, 2003; 3(2): 75 - 78. [Abstract] [Full Text] |
||||
![]() |
M. Zeyda, G. Staffler, V. Horejsi, W. Waldhausl, and T. M. Stulnig LAT Displacement from Lipid Rafts as a Molecular Mechanism for the Inhibition of T Cell Signaling by Polyunsaturated Fatty Acids J. Biol. Chem., August 2, 2002; 277(32): 28418 - 28423. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pandey, N. Ibarrola, I. Kratchmarova, M. M. Fernandez, S. N. Constantinescu, O. Ohara, S. Sawasdikosol, H. F. Lodish, and M. Mann A Novel Src Homology 2 Domain-containing Molecule, Src-like Adapter Protein-2 (SLAP-2), Which Negatively Regulates T Cell Receptor Signaling J. Biol. Chem., May 17, 2002; 277(21): 19131 - 19138. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Alonso and J. Millan The role of lipid rafts in signalling and membrane trafficking in T lymphocytes J. Cell Sci., March 13, 2002; 114(22): 3957 - 3965. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Sedwick and A. Altman Ordered Just So: Lipid Rafts and Lymphocyte Function Sci. Signal., March 5, 2002; 2002(122): re2 - re2. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Schade and A. D. Levine Lipid Raft Heterogeneity in Human Peripheral Blood T Lymphoblasts: A Mechanism for Regulating the Initiation of TCR Signal Transduction J. Immunol., March 1, 2002; 168(5): 2233 - 2239. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Y. Hawash, K. P. Kesavan, A. I. Magee, R. L. Geahlen, and M. L. Harrison The Lck SH3 Domain Negatively Regulates Localization to Lipid Rafts through an Interaction with c-Cbl J. Biol. Chem., February 8, 2002; 277(7): 5683 - 5691. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Gringhuis, E. A. M. Papendrecht-van der Voort, A. Leow, E. W. N. Levarht, F. C. Breedveld, and C. L. Verweij Effect of Redox Balance Alterations on Cellular Localization of LAT and Downstream T-Cell Receptor Signaling Pathways Mol. Cell. Biol., January 15, 2002; 22(2): 400 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Martin, H. Schneider, A. Azouz, and C. E. Rudd Cytotoxic T Lymphocyte Antigen 4 and CD28 Modulate Cell Surface Raft Expression in Their Regulation of T Cell Function J. Exp. Med., December 3, 2001; 194(11): 1675 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arcaro, C. Gregoire, T. R. Bakker, L. Baldi, M. Jordan, L. Goffin, N. Boucheron, F. Wurm, P. A. van der Merwe, B. Malissen, et al. CD8{beta} Endows CD8 with Efficient Coreceptor Function by Coupling T Cell Receptor/CD3 to Raft-associated CD8/p56lck Complexes J. Exp. Med., November 19, 2001; 194(10): 1485 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Li, Y. Liu, and S. Ladisch Enhancement of Epidermal Growth Factor Signaling and Activation of Src Kinase by Gangliosides J. Biol. Chem., November 9, 2001; 276(46): 42782 - 42792. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Veri, K. E. DeBell, M.-C. Seminario, A. DiBaldassarre, I. Reischl, R. Rawat, L. Graham, C. Noviello, B. L. Rellahan, S. Miscia, et al. Membrane Raft-Dependent Regulation of Phospholipase C{gamma}-1 Activation in T Lymphoc |